• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Microbiome and Cancers, With Focus on Genitourinary Tumors.

作者信息

Cimadamore Alessia, Santoni Matteo, Massari Francesco, Gasparrini Silvia, Cheng Liang, Lopez-Beltran Antonio, Montironi Rodolfo, Scarpelli Marina

机构信息

Section of Pathological Anatomy, School of Medicine, United Hospitals, Polytechnic University of the Marche Region, Ancona, Italy.

Oncology Unit, Macerata Hospital, Macerata, Italy.

出版信息

Front Oncol. 2019 Mar 26;9:178. doi: 10.3389/fonc.2019.00178. eCollection 2019.

DOI:10.3389/fonc.2019.00178
PMID:30972292
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6443990/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/253b/6443990/9e0c216508de/fonc-09-00178-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/253b/6443990/6b0f91e8c834/fonc-09-00178-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/253b/6443990/9e0c216508de/fonc-09-00178-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/253b/6443990/6b0f91e8c834/fonc-09-00178-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/253b/6443990/9e0c216508de/fonc-09-00178-g0002.jpg

相似文献

1
Microbiome and Cancers, With Focus on Genitourinary Tumors.微生物组与癌症，重点关注泌尿生殖系统肿瘤
Front Oncol. 2019 Mar 26;9:178. doi: 10.3389/fonc.2019.00178. eCollection 2019.
2
The Microbiome and Genitourinary Cancer: A Collaborative Review.微生物组与泌尿生殖系统肿瘤：协作综述。
Eur Urol. 2019 Apr;75(4):637-646. doi: 10.1016/j.eururo.2018.12.043. Epub 2019 Jan 15.
3
Genitourinary Tumors: Update on Molecular Biomarkers for Diagnosis, Prognosis and Prediction of Response to Therapy.泌尿生殖系统肿瘤：分子生物标志物在诊断、预后和预测治疗反应方面的最新进展。
Curr Drug Metab. 2019;20(4):305-312. doi: 10.2174/1389200220666190225124352.
4
Use of immunotherapy in clinical management of genitourinary cancers - a review.免疫疗法在泌尿生殖系统癌症临床管理中的应用——综述。
Cancer Treat Res Commun. 2022;31:100564. doi: 10.1016/j.ctarc.2022.100564. Epub 2022 Apr 17.
5
Selected news from the 2014 Genitourinary Cancers Symposium: translating novel strategies into clinical practice.2014年泌尿生殖系统癌症研讨会精选新闻：将新策略转化为临床实践
Future Oncol. 2014 Nov;10(14):2103-6. doi: 10.2217/fon.14.185.
6
Current Role of Checkpoint Inhibitors in Urologic Cancers.检查点抑制剂在泌尿系统癌症中的当前作用。
Cancer Treat Res. 2018;175:241-258. doi: 10.1007/978-3-319-93339-9_11.
7
Optimal Selection of Patients with Genitourinary Cancers for Anti-PD1/PD-L1 Treatment with a Focus on Urothelial and Renal Cell Carcinoma.泌尿生殖系统癌症患者抗PD1/PD-L1治疗的最佳选择，重点关注尿路上皮癌和肾细胞癌。
Eur Urol Focus. 2022 Jul;8(4):907-909. doi: 10.1016/j.euf.2022.07.002. Epub 2022 Jul 30.
8
[Immunotherapy in the treatment of genitourinary cancers].[免疫疗法在泌尿生殖系统癌症治疗中的应用]
Magy Onkol. 2016 Mar 2;60(1):41-5. Epub 2016 Feb 8.
9
Editorial: Emerging Biomarkers in Genitourinary Tumors.社论：泌尿生殖系统肿瘤中的新兴生物标志物
Front Oncol. 2019 Apr 26;9:326. doi: 10.3389/fonc.2019.00326. eCollection 2019.
10
Current Landscape of Immunotherapy in Genitourinary Malignancies.当前泌尿生殖系统恶性肿瘤免疫治疗全景。
Adv Exp Med Biol. 2020;1244:107-147. doi: 10.1007/978-3-030-41008-7_6.

引用本文的文献

1
Unveiling the impact of 16S rRNA gene intergenomic variation on primer design and gut microbiome profiling.揭示16S rRNA基因基因组间变异对引物设计和肠道微生物群分析的影响。
Front Microbiol. 2025 May 2;16:1573920. doi: 10.3389/fmicb.2025.1573920. eCollection 2025.
2
Advances in human microbiome and prostate cancer research.人类微生物组与前列腺癌研究进展
Front Immunol. 2025 Apr 14;16:1576679. doi: 10.3389/fimmu.2025.1576679. eCollection 2025.
3
Prostate Tissue Microbiome in Patients with Prostate Cancer: A Systematic Review.

本文引用的文献

1
Programmed Cell Death 1 (PD-1) Ligand (PD-L1) Expression in Solid Tumors As a Predictive Biomarker of Benefit From PD-1/PD-L1 Axis Inhibitors: A Systematic Review and Meta-Analysis.实体瘤中程序性细胞死亡蛋白1（PD-1）配体（PD-L1）的表达作为从PD-1/PD-L1轴抑制剂中获益的预测生物标志物：一项系统评价和荟萃分析
JCO Precis Oncol. 2017 Nov;1:1-15. doi: 10.1200/PO.16.00030.
2
The Microbiome and Genitourinary Cancer: A Collaborative Review.微生物组与泌尿生殖系统肿瘤：协作综述。
Eur Urol. 2019 Apr;75(4):637-646. doi: 10.1016/j.eururo.2018.12.043. Epub 2019 Jan 15.
3
Analysis of the Enteric Microbiome: First Tentative Steps Towards a Comprehensive Work-up of Prostate Cancer?
前列腺癌患者的前列腺组织微生物群：一项系统综述。
Cancers (Basel). 2024 Apr 18;16(8):1549. doi: 10.3390/cancers16081549.
4
The Molecular Basis and Clinical Consequences of Chronic Inflammation in Prostatic Diseases: Prostatitis, Benign Prostatic Hyperplasia, and Prostate Cancer.前列腺疾病中慢性炎症的分子基础及临床后果：前列腺炎、良性前列腺增生和前列腺癌。
Cancers (Basel). 2023 Jun 8;15(12):3110. doi: 10.3390/cancers15123110.
5
Potential role of gut microbiota in prostate cancer: immunity, metabolites, pathways of action?肠道微生物群在前列腺癌中的潜在作用：免疫、代谢产物、作用途径？
Front Oncol. 2023 May 17;13:1196217. doi: 10.3389/fonc.2023.1196217. eCollection 2023.
6
New insights and options into the mechanisms and effects of combined targeted therapy and immunotherapy in prostate cancer.前列腺癌联合靶向治疗与免疫治疗的机制及效果的新见解与选择
Mol Ther Oncolytics. 2023 Apr 29;29:91-106. doi: 10.1016/j.omto.2023.04.007. eCollection 2023 Jun 15.
7
Microbiome and Prostate Cancer: A Novel Target for Prevention and Treatment.微生物组与前列腺癌：预防和治疗的新靶点。
Int J Mol Sci. 2023 Jan 12;24(2):1511. doi: 10.3390/ijms24021511.
8
The Role of the Human Microbiome in the Pathogenesis of Pain.人类微生物组在疼痛发病机制中的作用。
Int J Mol Sci. 2022 Oct 31;23(21):13267. doi: 10.3390/ijms232113267.
9
The role of gut microbiome in immune modulation in metastatic renal cell carcinoma.肠道微生物群在转移性肾细胞癌免疫调节中的作用。
Ther Adv Med Oncol. 2022 Sep 8;14:17588359221122714. doi: 10.1177/17588359221122714. eCollection 2022.
10
Precision Medicine: An Optimal Approach to Patient Care in Renal Cell Carcinoma.精准医学：肾癌患者护理的最佳方法
Front Med (Lausanne). 2022 Jun 14;9:766869. doi: 10.3389/fmed.2022.766869. eCollection 2022.
肠道微生物群分析：迈向前列腺癌全面检查的初步尝试？
Eur Urol. 2018 Nov;74(5):583-584. doi: 10.1016/j.eururo.2018.07.009. Epub 2018 Jul 20.
4
Metabolic Biosynthesis Pathways Identified from Fecal Microbiome Associated with Prostate Cancer.从与前列腺癌相关的粪便微生物组中鉴定出的代谢生物合成途径。
Eur Urol. 2018 Nov;74(5):575-582. doi: 10.1016/j.eururo.2018.06.033. Epub 2018 Jul 12.
5
Compositional differences in gastrointestinal microbiota in prostate cancer patients treated with androgen axis-targeted therapies.雄激素轴靶向治疗前列腺癌患者胃肠道微生物群落组成的差异。
Prostate Cancer Prostatic Dis. 2018 Nov;21(4):539-548. doi: 10.1038/s41391-018-0061-x. Epub 2018 Jul 9.
6
Profiling the Urinary Microbiota in Male Patients With Bladder Cancer in China.分析中国男性膀胱癌患者的尿微生物组。
Front Cell Infect Microbiol. 2018 May 31;8:167. doi: 10.3389/fcimb.2018.00167. eCollection 2018.
7
Re: Gut Microbiome Influences Efficacy of PD-1-based Immunotherapy Against Epithelial Tumors.回复：肠道微生物群影响基于PD-1的免疫疗法对上皮肿瘤的疗效。
Eur Urol. 2018 Oct;74(4):521-522. doi: 10.1016/j.eururo.2018.05.033. Epub 2018 Jun 8.
8
Negative association of antibiotics on clinical activity of immune checkpoint inhibitors in patients with advanced renal cell and non-small-cell lung cancer.抗生素对晚期肾细胞癌和非小细胞肺癌患者免疫检查点抑制剂临床疗效的负相关作用。
Ann Oncol. 2018 Jun 1;29(6):1437-1444. doi: 10.1093/annonc/mdy103.
9
Effectiveness of anti-PD-1/PD-L1 antibodies in urothelial carcinoma patients with different PD-L1 expression levels: a meta-analysis.抗PD-1/PD-L1抗体在不同PD-L1表达水平的尿路上皮癌患者中的疗效：一项荟萃分析。
Oncotarget. 2018 Jan 13;9(15):12400-12407. doi: 10.18632/oncotarget.24249. eCollection 2018 Feb 23.
10
The microbiome and cancer.微生物组与癌症。
J Pathol. 2018 Apr;244(5):667-676. doi: 10.1002/path.5047. Epub 2018 Mar 12.